SINGAPORE, July 1, 2025 /PRNewswire/ -- The journey of Teamplete Sdn Bhd, from its beginnings in 1985 as an oil palm plantation contractor in Johor, to its current standing as a thriving plantation ...

SINGAPORE, July 1, 2025 /PRNewswire/ -- The journey of Teamplete Sdn Bhd, from its beginnings in 1985 as an oil palm plantation contractor in Johor, to its current standing as a thriving plantation ...

Updates reported EPS guidance to $10.77 - $11.07 and comparable EPS guidance to $11.30 - $11.60 (1) Updates Enterprise organic net sales to decline (6)% - (4)%, reported operating income to grow 666% ...

• Evidence of Electric Hydrogen's continued commitment to meet demand for large-scale and low-cost renewable hydrogen systems in Europe LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Electric Hydrogen, ...

CGTN published an article on Chinese President Xi Jinping’s proposal of the Global Governance Initiative at the “SCO Plus” Meeting. As the fourth major global initiative proposed by China, the article ...

HERNEXEOS ® (zongertinib tablets) has been approved based on an objective response rate of 71% (N=75), as demonstrated in the Beamion-LUNG 1 clinical trial 1 Zongertinib recently received Breakthrough ...

A Media Snippet accompanying this announcement is available by clicking on this link. MANILA, Philippines, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Today, the Philippines officially declared the waters ...

CGTN published an article on China's upcoming V-Day commemorations in Beijing. Through recounting the story of the American Flying Tigers' assistance to China in its battle against Japanese invaders, ...

First F1 ® Allwyn Global Community Award sees local Dutch initiative presented with the trophy and €100,000 donation from Allwyn to support its impact on the local community Winner has been recognised ...

VICTORIA, Seychelles, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Bitget, the world’s leading cryptocurrency exchange and Web3 company, has been spotlighted in a newly released CoinDesk Market Data Deep-Dive ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...